Ketotifenum [INN-Latin] en es it fr

Ketotifenum [INN-Latin] Brand names, Ketotifenum [INN-Latin] Analogs

Ketotifenum [INN-Latin] Brand Names Mixture

  • No information avaliable

Ketotifenum [INN-Latin] Chemical_Formula


Ketotifenum [INN-Latin] RX_link

Ketotifenum [INN-Latin] fda sheet

Ketotifenum_[INN-Latin] FDA

Ketotifenum [INN-Latin] msds (material safety sheet)

Ketotifenum_[INN-Latin] MSDS

Ketotifenum [INN-Latin] Synthesis Reference

No information avaliable

Ketotifenum [INN-Latin] Molecular Weight

204.292 g/mol

Ketotifenum [INN-Latin] Melting Point

264-265 oC

Ketotifenum [INN-Latin] H2O Solubility

210 mg/mL

Ketotifenum [INN-Latin] State


Ketotifenum [INN-Latin] LogP


Ketotifenum [INN-Latin] Dosage Forms


Ketotifenum [INN-Latin] Indication

For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.

Ketotifenum [INN-Latin] Pharmacology

Levamisole is a synthetic imidazothiazole derivative that has been widely used in treatment of worm infestations in both humans and animals. As an anthelmintic, it probably works by targeting the nematode nicotinergic acetylcholine receptor. As an immunomodulator, it appears that Levamisole is an immunostimulant which has been shown to increase NK cells and activated T-cells in patients receiving this adjuvantly along with 5FU for Stage III colon cancer.

Ketotifenum [INN-Latin] Absorption

Levamisole is rapidly absorbed (2 hours) from the gastrointestinal tract.

Ketotifenum [INN-Latin] side effects and Toxicity

LD50 = 40 mg/kg (Pigs, subcutaneous); LD50 = 180 mg/kg (rat, oral)

Ketotifenum [INN-Latin] Patient Information

Ketotifenum [INN-Latin] Organisms Affected

Humans and other mammals